Inventor profile of:

Gaetano Brambilla

City:

Parma

Country:

Italy

Published Applications:

45

Last publication date:

2020-05-07

Top Assignees for applications by Gaetano Brambilla

The entities that hold a legal rights for patent applications filed by inventor Brambilla Gaetano:

Recent patent applications by Brambilla Gaetano

Gaetano Brambilla from Parma, IT has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2020-05-07
US20200138724A1
Human necessities

CRYSTALLINE MICROPARTICLES OF A BETA-AGONIST COATED WITH A FATTY ACID

#2 | 2020-03-19
US20200085729A1
Human necessities

Pharmaceutical solution formulations for pressurized metered dose inhalers

#3 | 2017-03-23
US20170080168A1
Human necessities

Aerosol inhalation device

#4 | 2017-03-09
US20170065518A1
Human necessities

Pharmaceutical solution formulations for pressurised metered dose inhalers

#5 | 2016-11-10
US20160324792A1
Human necessities

Crystalline microparticles of a beta-agonist coated with a fatty acid

#6 | 2015-12-10
US20150352127A1
Human necessities

Inhalation particles comprising a combination of an anticholinergic, a corticosteroid and a beta-adrenergic

#7 | 2015-02-19
US20150050350A1
Human necessities

Pharmaceutical formulations for dry powder inhalers

#8 | 2014-03-06
US20140060531A1
Human necessities

AEROSOL INHALATION DEVICE

#9 | 2013-04-11
US20130089617A1
Human necessities

CRYSTALLINE MICROPARTICLES OF A BETA-AGONIST COATED WITH A FATTY ACID

#10 | 2012-12-06
US20120308613A1
Human necessities

FORMULATIONS FOR USE IN INHALER DEVICES

#11 | 2012-05-22
US10257790
-

Formulations for use in inhaler devices

#12 | 2012-03-08
US20120055468A1
Human necessities

METERED-DOSE INHALER ACTUATOR, METERED-DOSE INHALER AND METHOD OF USING THE SAME

#13 | 2012-03-08
US20120055467A1
Human necessities

METERED-DOSE INHALER AND METHOD OF USING THE SAME

#14 | 2011-05-05
US20110100361A1
Human necessities

PRESSURISED METERED DOSE INHALERS (MDI)

#15 | 2011-04-07
US20110081301A1
Human necessities

Pharmaceutical aerosol formulations of formoterol and beclometasone dipropionate

#16 | 2011-03-17
US20110061651A1
Human necessities

Formoterol superfine formulation

#17 | 2010-10-28
US20100269825A1
Human necessities

INHALATION PARTICLES COMPRISING A SALT OF 8-HYDROXY-2-[[(1R)-2-(4-METHOXYPHENYL)-1-METHYLETHYL]AMINO] ETHYL]-2(1H)-QUINOLINONE AND A CORTICOSTEROID

#18 | 2010-06-22
US10612072
-

Pressurised metered dose inhalers (MDI)

#19 | 2010-02-25
US20100047184A1
Human necessities

PHARMACEUTICAL COMPOSITIONS CONTAINING AN EFFERVESCENT ACID-BASE COUPLE

#20 | 2009-12-17
US20090311196A1
Human necessities

Pharmaceutical aerosol composition

#21 | 2009-10-29
US20090269412A1
Human necessities

Pharmaceutical formulations for dry powder inhalers

#22 | 2009-10-22
US20090263488A1
Human necessities

PRESSURISED METERED DOSE INHALERS CONTAINING SOLUTIONS OF BETA-2 AGONISTS

#23 | 2009-10-13
US10435032
-

Pharmaceutical aerosol composition

#24 | 2009-07-30
US20090192187A1
Chemistry; metallurgy

DRY POWDER FORMULATION COMPRISING AN ANTICHOLINERGIC DRUG

#25 | 2009-06-02
US10257886
-

Pharmaceutical formulations for dry powder inhalers

#26 | 2009-05-21
US20090130026A1
Human necessities

PHARMACEUTICAL SOLUTION FORMULATIONS FOR PRESSURISED METERED DOSE INHALERS

#27 | 2009-01-22
US20090020114A1
Human necessities

METERED DOSE INHALER ACTUATOR

#28 | 2008-10-09
US20080247965A1
Human necessities

PRESSURISED METERED DOSE INHALERS (MDI)

#29 | 2008-05-22
US20080115782A1
Human necessities

Pressurized metered dose inhalers (MDI) containing a solution comprising ipratropium bromide, HFA propellant, and co-solvent and comprising a container with a specific internal surface composition and/or lining

#30 | 2008-03-25
US9831888
-

Pressurised metered dose inhalers (MDI)

#31 | 2007-05-29
US10244519
-

Pressurised metered dose inhalers (MDI)

#32 | 2006-11-16
US20060257324A1
Human necessities

Pharmaceutical solution formulations for pressurised metered dose inhalers

#33 | 2006-06-08
US20060120966A1
Human necessities

Salmeterol superfine formulation

#34 | 2006-04-20
US20060083693A1
Human necessities

Stable pharmaceutical solution formulations for pressurised metered dose inhalers

#35 | 2006-03-28
US10640005
-

Stable pharmaceutical solution formulations for pressurized metered dose inhalers

#36 | 2005-11-22
US10030101
-

Formulations of steroid solutions for inhalatory administration

#37 | 2005-11-15
US10204307
-

Formulations containing an anticholinergic drug for the treatment of chronic obstructive pulmonary disease

#38 | 2005-09-22
US20050209207A1
Human necessities

Aerosol formulations containing esters of 3,17-dihydroxy oestratriene derivatives for pulmonary delivery

#39 | 2005-09-15
US20050201950A1
Human necessities

Pharmaceutical formulations for dry powder inhalers in the form of hard-pellets

#40 | 2005-07-14
US20050154013A1
Human necessities

Pressurised metered dose inhalers containing solutions of beta-2 agonists

#41 | 2005-07-14
US20050152846A1
Human necessities

Formoterol superfine formulation

#42 | 2005-06-30
US20050142071A1
Human necessities

Pressurised metered dose inhalers (MDI)

#43 | 2005-06-16
US20050129621A1
Human necessities

Aerosol formulations for pulmonary administration of medicaments to produce a systemic effect

#44 | 2005-04-26
US10257368
-

Pharmaceutical formulations for dry powder inhalers in the form of hard-pellets

#45 | 2005-02-17
US20050034720A1
Human necessities

Aerosol inhaler

InventorID:

186400 ⎘